High titers of autoantibodies directed to isotypic determinants of IgD were produced by inoculation of syngeneic monoclonal IgD, conjugated covalently to keyhole limpet hemocyanin, into adult or neonatal inbred mice. Antiidiotypic antibodies were induced at the same time. The average affinity of the mouse antibodies (Ka 9 107 M-1) is similar to that of rabbit anti-IgD and of syngeneic anti-IgE induced by the same procedure. Results indicate that B cells of the mice are not tolerant to serum IgD and that tolerance is maintained at the level of T cells. Direct interaction of the syngeneic anti-IgD with cell-surface IgD was minimal, and there was no convincing evidence that cell-surface IgD was down-regulated in the anti-IgD-producing mice. Further studies, preferably employing monoclonal anti-IgD, are required to determine whether epitopes on cell-surface IgD can be recognized by syngeneic anti-IgD. The ability to generate in vivo high titers of anti-IgD should facilitate the production of such monoclonal antibodies.
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Recently we reported the induction of high titers (to 1 mg/ ml) of syngeneic anti-IgE with isotypic specificity in adult A/J mice (1) . The immunogen used was a copolymer of keyhole limpet hemocyanin (KLH) with an A/J monoclonal antibody (mAb) of the IgE class. Results indicated that mice are not tolerant at the level of B cells to their own IgE. The fact that the copolymer was immunogenic, whereas monomeric IgE was not, indicated that tolerance is mediated by T cells and can be broken by the use of a foreign carrier molecule, KLH. These observations permitted the production of syngeneic anti-IgE mAbs (2), which we are using in studies of regulation of IgE synthesis.
The capacity to produce high titers of syngeneic anti-IgE suggested that the same methods might be applied to the induction of syngeneic anti-IgD because IgD and IgE both exist at very low concentrations in normal mouse serum. In fact, existence of circulating autoantibodies to human IgD in rheumatic diseases has been reported (3) . However, because IgD is expressed on the cell surface of >90% of B cells, it seemed possible that self-tolerance to IgD might be more firmly established than self-tolerance to IgE. We here describe the induction of high titers of syngeneic anti-IgD and report on the affinities and specificity of such antibodies. The results are relevant to questions of self-tolerance and autoimmunity and may permit the eventual production of syngeneic anti-IgD mAbs for use in studies of regulation of the immune system.
The significance of surface IgD in regulation has been demonstrated in many investigations (4) (5) (6) (7) (8) (9) (10) . For example, it has been shown that treatment of mice from birth with allogeneic anti-IgD suppresses cell-surface IgD expression and down-regulates the production of antibodies of all isotypes to antigens administered s.c. or i.p. (4, 5, 8) . However, the greatly reduced numbers of remaining 4+, 5-B cells in such mice were shown to be actually hyperresponsive to antigens injected i.v. (6, 8) .
MATERIALS AND METHODS Mice. BALB/c mice were obtained from The Jackson Laboratory. Mice were 5-8 weeks old at the start of each experiment. Neonatal mice were 2 days old at the first antigen inoculation.
Monoclonal IgD. Two IgDK preparations were used; both were derived from BALB/c myeloma cell lines (TEPC-1033 and TEPC-1017) developed by F. Finkelman, M. Potter, and collaborators (11) . The cell lines were grown as ascites cells in pristane-primed BALB/c mice. Purification of IgD was done by modifying slightly the method of Finkelman et al. (11) . Our procedure includes two precipitations with ammonium sulfate followed by chromatography on DEAEcellulose in 0.03 M sodium phosphate buffer, pH 8.3. The IgD was obtained together with IgG in the fall-through fraction; IgG was removed by repeated passage through a protein A-Sepharose column (Sigma) in a high-salt buffer (0.1 M sodium phosphate/i M sodium chloride, pH 8.3). Finally, gel filtration was done on Sephacryl S-300 (Pharmacia). Purification was monitored by double diffusion in agarose gel, immunoelectrophoresis, and NaDodSO4/ PAGE. In a nonreducing gel the final product migrated as a single major band with an apparent Mr of 125,000 (cf. ref. 12); gel filtration indicated a Mr for both TEPC-1033 and TEPC-1017 somewhat higher than that of IgE, a result consistent with the presence of a dimer of IgD (11) . A portion of each purified IgD preparation was trace-labeled with 1251 by the chloramine-T method (13) . Samples were tested for degradation by gel filtration shortly before using the material in RIAs. Small amounts of breakdown products were detected, but the major product was of high molecular weight.
Conjugation of IgD with KLH. Conjugates were prepared (14) by mixing 10-mg quantities of purified IgD and KLH in a final volume of 2 ml in 0.1 M sodium phosphate buffer, pH 6.0. Glutaraldehyde was added in an amount equal to 20 mol per mol of IgD. After approximately one-half hour of incubation at room temperature, the mixture became cloudy; the reaction was then quenched with 1 M L-lysine, and the mixture was then dialyzed against neutral phosphate-buffered saline. Affinity-Purification of Rabbit and Mouse Anti-IgD. Rabbit anti-TEPC-1017 was affinity-purified from antiserum on a Sepharose conjugate of TEPC-1033. BALB/c anti-TEPC-1033 (IgG fraction) was affinity-purified on a Sepharose-TEPC-1017 conjugate. NaSCN (3 M) was used for elution.
Assay for IgD in Serum. Wells of microtiter plates were coated with affinity-purified rabbit anti-IgD (TEPC-1017; 1 ,ug/ml), saturated with 2.5% horse serum, and then exposed to varying dilutions of serum. Development was done with '25I-labeled affinity-purified rabbit anti-IgD (40 ng in 0.1 ml). As a standard we used purified IgD (TEPC-1033). To determine whether mouse anti-IgD interacted with surface IgD, cells were incubated first with affinity-purified syngeneic mouse anti-IgD (100 ug/ml), or with dilutions of mouse serum initially containing 70 ,ug of anti-IgD per ml, and then stained with FITC-labeled goat anti-mouse IgG (American Qualex, Lamirada, CA). In some experiments cells were exposed to mouse anti-IgD for 10 min before addition of goat anti-IgD or F(ab')2 fragments of rabbit anti-IgD to determine whether mouse anti-IgD would interfere with binding of the heterologous anti-IgD. Cells were stained with appropriate FITC-labeled reagents, specific for goat or rabbit immunoglobulin.
RESULTS
Induction of Syngeneic Anti-IgD Antibodies in BALB/c Mice. Table 1 shows that significant titers of anti-IgD antibodies (to =220 ,ug/ml) can be induced in adult BALB/c mice by two inoculations in CFA of a conjugate of KLH with IgD (TEPC-1033). Sera were assayed on wells coated with a different myeloma IgD (TEPC-1017). Significant, but considerably lower, titers of anti-IgD were also elicited with unconjugated IgD as the immunogen. Anti-IgD antibodies could also be elicited when the first inoculation was given to BALB/c mice at 2 days of age (Table 2 ); in this case unconjugated TEPC-1033 was about as effective as the KLH-TEPC-1033 polymer. Concentrations of anti-IgD elicited by the polymer were considerably lower, however, in neonatal than in adult mice (Tables 1 and 2 ). In contrast to TEPC-1033, TEPC-1017 was a very poor immunogen in neonatal mice, although both IgD preparations induced anti-IgD in adult recipients when administered as the copolymer with KLH. Neonatal mice given unconjugated TEPC-1017 did exhibit low-to-significant titers (to 7 ,g/ml) at a later bleeding (day 73; data not shown). Specificity of the anti-IgD antibodies is shown by Tables 3  and 4 ; labeled anti-Fc of IgG was used as the developing reagent in these assays. Binding to IgD-coated wells was inhibited to a large extent by 10 1Lg of added IgD but not by 10 tug of monoclonal mouse immunoglobulins of other isotypes ( Table 3 ). The failure to observe complete inhibition by soluble IgD suggests that the effective affinity (avidity) of binding of anti-IgD is much greater for IgD coated onto a surface than for IgD in solution-probably because of bivalent attachment of antibodies to surface-bound IgD.
Further evidence for specificity was obtained with 125I-labeled affinity-purified anti-IgD, prepared from a pool of sera from adult BALB/c mice immunized with the KLH-TEPC-1033 conjugate (Table 4 ). Significant binding to wells coated with IgD was seen, but not to wells coated with immunoglobulins of other isotypes. Data in this table also provide evidence for specificity of the affinity-purified rabbit anti-IgD. The results obtained with rabbit anti-mouse Fab (controls) demonstrate that the wells were effectively coated with immunoglobulin.
IgM and IgG Content of Syngeneic Anti-IgD. An estimation of isotypes in the BALB/c anti-IgD (TEPC-1033) was made by a solid-phase RIA using wells coated with IgD (TEPC-1017). After exposure to varying dilutions of antiserum, Antisera were prepared in adult BALB/c mice against a copolymer of KLH and TEPC-1033 (IgD), except for the pool (last column) that was prepared from sera of five other mice immunized with unconjugated TEPC-1033. RIAs were done on plates the wells of which were coated with IgD (TEPC-1017). The amount of antibody present per well was 4-8 ng and was constant for a given antiserum. Inhibitors (10 ,ug of each) were purified BALB/c myeloma proteins or a hybridoma product (TIB-142), except for normal BALB/c IgG (NIgG). Each experiment was done in duplicate, and both results are shown. The anti-IgD antibody titers of the four antisera and the pool were 169, 88, 135, 103, and 7 ,ug/ml, respectively. ND, not done.
wells were developed with affinity-purified '25I-labeled rabbit anti-mouse IgM or goat anti-mouse Fc fragment. The relative binding efficiencies of the labeled anti-IgM and anti-Fc were determined by using known amounts of IgM or IgG mAbs specific for the phenylarsonate hapten on trays coated with a bovine serum albumin-phenylarsonate conjugate. Four different pools of syngeneic anti-IgD antisera were used. (The pools are those listed in Table 5 .) The calculated ratios of IgM to IgG antibodies were 1:10, 1:23, 1:32, and 1:58 for the four pools. We were unable to detect significant concentrations of either IgM or IgG anti-IgD antibodies in normal adult BALB/c sera used as controls.
Affinities of Syngeneic (BALB/c) and Rabbit Anti-Mouse IgD. Data on average binding affinities are shown in Table 5 . For adult mice and for mice that received their initial inoculation at 2 days of age, average Ka values range from 0.6-3.5 x 107 M -1. There are no major differences among adult and neonatal recipients. Affinity-purified rabbit antiIgD (pooled serum from two rabbits) had an average Ka of 2.5 x 107 M-1 Content of Antiidiotypic Antibodies in Syngeneic Anti-IgD.
For these measurements we used BALB/c antiserum pooled from adult mice immunized with KLH-TEPC-1033. Assays were done in the liquid phase; complexes were precipitated with rabbit anti-mouse Fc fragment. As ligand we used increasing amounts of 125I-labeled TEPC-1033 (the immunogen) or TEPC-1017, together with a constant volume of (Fig. 1) . The unlabeled rabbit antibody was much more effective, however, in displacing the labeled rabbit antibody. Even at an extremely high level (50 ug) mouse anti-IgD caused only 70%o inhibition of binding of the labeled rabbit anti-IgD, whereas 5 ,ug of unlabeled rabbit antibody caused 92% inhibition.
Concentrations of IgD in Normal and Immune Serum. Nonimmune sera of four adult BALB/c mice were found to have IgD concentrations ranging from 380 to 900 ng/ml with a mean value of 560 ng/ml. IgD was not detectable (concentration <25 ng/ml) in the sera of four mice that had been immunized three times with KLH-TEPC-1033 in CFA.
Test for Direct Binding to Cell Surfaces by Mouse Anti-IgD and Competition Experiments. Cell-staining data (Table 6) showed the following: (i) mouse anti-IgD, examined as serum or as affinity-purified antibody, showed little binding to the surface of normal BALB/c spleen cells (column 3). (ii) High concentrations of mouse anti-IgD failed to inhibit significantly the binding of heterologous (goat or rabbit) anti-IgD to cell surfaces (columns 4 and 5). High percentages of cells were stained by anti-I-Ad (positive control; column 6), using the same second antibody (FITC-labeled anti-IgG) that was used for the experiments with syngeneic anti-IgD.
Effect of Induction of Syngeneic Anti-IgD on Surface Immunoglobulin Expression. The percentages of IgM-or IgDbearing cells in anti-IgD-producing mice were only marginally reduced in the spleen. The average percentages of spleen cells stained with goat anti-IgM or goat anti-IgD were 43% and 45%, respectively, for two mice immunized as adults with KLH (controls) vs. 33% and 40% for three mice immunized with KLH-IgD. The average values for three mice immunized with KLH-IgD from birth were somewhat lower (28% and 27%, respectively). No significant differences in staining for IgM or IgD, as compared with normal mice, were seen in lymph node suspensions from mice immunized as adults or neonates. Percentages of lymph node cells stained ranged from 18% to 25% for anti-IgM and from 15% to 28% for anti-IgD. Mean fluorescence values for lymph node cells stained with FITC-labeled goat anti-IgD were indistinguishable for anti-IgD-producing and control mice; that is, the levels of surface IgD were unchanged.
Staining with anti-mouse IgG did not show any increases over the background seen with KLH-immune mice: that is, no detectable IgG anti-IgD bound to B cells despite the high concentration of circulating anti-IgD (data not shown).
DISCUSSION
The data indicate that substantial titers (>200 ,ug/ml) of syngeneic anti-IgD can be induced in adult BALB/c mice by immunization with an IgD BALB/c myeloma protein conjugated to KLH and emulsified in CFA. Unconjugated IgD was also effective, but lower concentrations of anti-IgD were produced in adult mice. Although some IgM anti-IgD antibodies were induced, 90-98% were IgG after hyperimmunization. Specificity for IgD was established by two different assays: one involved direct binding and the other was a competition assay. Significant concentrations of antiidiotypic antibodies, specific for the immunogen, were also present in immune sera.
The average binding affinities, Ka, of the anti-IgD antibodies were of the order of 107 M 1; these affinities are only moderately high for antiprotein antibodies but are orders of magnitude greater than those generally reported for human rheumatoid factors (see ref. 19) and are similar to the average affinity of four rabbit anti-IgD (Table 5) . We should indicate, however, that the rabbit preparation contained some antibodies of very high affinity that were not found in the mouse anti-IgD (data not shown). These results are consistent with the possibility that our rabbit anti-IgD reacts predominantly with epitopes on IgD not recognized by mouse anti-IgD. The apparent absence of syngeneic antibodies directed to cell-surface IgD could reflect tolerance of the mouse to those IgD epitopes exposed on the surface of B cells or adsorption by B cells of such antibodies as they are produced. The possibility that a small percentage of high-affinity antibodies, which may be absent in mouse anti-IgD, are responsible for staining cannot be ruled out.
That the number of circulating ,L u, + B cells was almost normal, even in mice immunized at 2 days of age, suggests that the circulating anti-IgD did not significantly downregulate B-cell maturation; this contrasts with previous observations on mice injected with homologous allo-anti-IgD from birth (5, 20, 21) .
The results indicate that adult BALB/c mice are not tolerant at the B-cell level to autologous IgD, although they may conceivably be tolerant to epitopes exposed on membrane IgD. Tolerance at the level of T cells is suggested by the greater effectiveness of KLH-IgD as an immunogen compared with unconjugated IgD. Thus, concentrations of IgD as well as of IgE in the mouse are evidently insufficient to induce B-cell tolerance. With mice immunized with IgD, syngeneic anti-IgD mAbs can potentially be produced in quantity-such antibodies may be useful for investigating the apparent failure of syngeneic anti-IgD to interact with cell-surface IgD. Also, if lack of cell staining by anti-IgD reflects adsorption of such anti-IgD by B cells, possibly monoclonal syngeneic anti-IgD that interacts with membrane IgD can be induced; such antibodies would be useful for studies of immune regulation.
